Naproxen Sodium Capsule, Liquid Filled
NDC Package 11673-651-78
Package Information
Naproxen Sodium capsules is do not take more than directedthe smallest effective dose should be useddrink a full glass of water with each doseif taken with food, this product may take longer to workadults and children 12 years and older:take 1 capsule every 8 to 12 hours while symptoms lastfor the first dose you may take 2 capsules within the first hourdo not exceed 2 capsules in any 8- to 12-hour perioddo not exceed 3 capsules in a 24-hour periodchildren under 12 years:ask a doctor. This formulation utilizes a capsule, liquid filled delivery system. Marketed by Target Corporation�, this product is identified by NDC 11673-651 and is authorized under FDA application NDA021920.
Identification & Billing
- RxCUI: 1112231 - naproxen sodium 220 MG Oral Capsule
- RxCUI: 1112231 - naproxen sodium 220 MG (as naproxen 200 MG) Oral Capsule
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 11673 - Target Corporation�
- 11673-651 - Naproxen Sodium
- 11673-651-78 - 1 BOTTLE, PLASTIC in 1 CARTON / 80 CAPSULE, LIQUID FILLED in 1 BOTTLE, PLASTIC
- 11673-651 - Naproxen Sodium
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 11673-651-78 identifies a specific commercial package of 1 bottle, plastic in 1 carton / 80 capsule, liquid filled in 1 bottle, plastic of Naproxen Sodium, a human over the counter drug labeled by Target Corporation�. This capsule, liquid filled is formulated for oral use and contains naproxen sodium as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Target Corporation� on December 08, 2025. The current certification is valid through December 31, 2027.
How is this Target Corporation� product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 11673065178. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.